Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |